Thermodynamic characterization of an intermediate state of human growth hormone
β Scribed by Isbuel Gomez-Orellana; Bruce Varinano; Judy Miura-Fraboni; Sam Milstein; Duncan R. Paton
- Book ID
- 105356538
- Publisher
- Cold Spring Harbor Laboratory Press
- Year
- 1998
- Tongue
- English
- Weight
- 668 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0961-8368
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The thermal denaturation of recombinant human growth hormone (rhGH) was studied by differential scanning calorimetry and circular dichroism spectroscopy (CD). The thermal unfolding is reversible only below pH 3.5, and under these conditions a single twoβstate transition was observed between 0 and 100Β°C. The magnitudes of the Ξ__H__ and Ξ__C~P~__ of this transition indicate that it corresponds to a partial unfolding of rhGH. This is also supported by CD data, which show that significant secondary structure remains after the unfolding. Above pH 3.5 the thermal denaturation is irreversible due to the aggregation of rhGH upon unfolding. This aggregation is prevented in aqueous solutions of alcohols such as nβpropanol, 2βpropanol, or 1,2βpropanediol (propylene glycol), which suggests that the selfβassociation of rhGH is caused by hydrophobic interactions. In addition, it was found that the native state of rhGH is stable in relatively high concentrations of propylene glycol (up to 45% v/v at pH 7β8 or 30% at pH 3) and that under these conditions the thermal unfolding is cooperative and corresponds to a transition from the native state to a partially folded state, as observed at acidic pH in the absence of alcohols. In higher concentrations of propylene glycol, the tertiary structure of rhGH is disrupted and the cooperativity of the unfolding decreases. Moreover, the CD and DSC data indicate that a partially folded intermediate with essentially native secondary structure and disordered tertiary structure becomes significantly populated in 70β80% propylene glycol.
π SIMILAR VOLUMES
## Production of proteins by recombinant DNA technology for use as pharmaceuticals requires the use of the most powerful tools of analytical protein chemistry in order to confirm purity and identity of the product and reliability of the process. Capillary electrophoresis is an emerging technology